Nilsson–ThorellC.B., MuscaluN., AndrénA.H.G., KjellstrandP.T.T., WieslanderA.P.Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes.Perit Dial Int1993; 13: 208–13.
2.
LindenT., ForsbäckG., DeppischR., HenleT., WieslanderA.3-deoxyglucosone, a promoter of advanced glycation products in fluids for peritoneal dialysis.Perit Dial Int1998; 18: 290–3.
3.
YamamotoT., SakakuraT., YamakawaM., HoriuchiN., HirataS., IritaniY.Clinical effects of long-term use of neutralized dialysate for continuous ambulatory peritoneal dialysis.Nephron1992; 60: 324–9.
4.
WieslanderA.P., NordinM.K., KjellstrandP.T.T., BobergU.C.Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929.Kidney Int1991; 40: 77–9.
5.
MartinsonE., WieslanderA., KjellstrandP., BobergU.Toxicity of heat sterilized peritoneal dialysis fluids is derived from degradation of glucose.ASAIO J1992; 38: M370–2.
6.
KjellstrandP., MartinsonE., WieslanderA., HolmquistB.Development of toxic degradation productions during heat sterilization of glucose-containing fluids for peritoneal dialysis: Influence of time and temperature.Perit Dial Int1995; 15: 26–32.
7.
WieslanderA.P., DeppischR., SvenssonE., ForsbäckG., SpeidelR., RippeB.In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis.Perit Dial Int1995; 15: 158–64.
8.
DawnayA.B., MillarD.J.Glycation and advanced glycation end-product formation with icodextrin and dextrose.Perit Dial Int1997; 17: 52–8.
9.
SimonsenO., RippeB., HeimbürgerO., ChristenssonA., HaraldssonB., StelinG.Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products [Abstract].J Am Soc Nephrol1999; 10: 322.
10.
CappelliG., BandianiG., CancariniG.C., FerianiM., Dell'AquilaR., SaffiotiS.Low concentrations of glucose degradation products in peritoneal dialysis fluids and their impact on biocompatibility parameters: Prospective cross-over study with a three-compartment bag. In: KhannaR., ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications, 1999; 15: 238–42.
11.
RippeB., SimonsenO., WieslanderA., LandgrenC.Clinical and physiological effects of a new, less toxic and less acidic fluid for peritoneal dialysis.Perit Dial Int1997; 17: 27–34.
12.
BrownleeM., CeramiA., VlassaraH.Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.New Engl J Med1988; 318: 1315–21.
13.
MiyataT., van Ypersele de StrihouC., KurokawaK., BaynesJ.W.Alterations in nonenzymatic biochemistry in uremia: Origin and significance of “carbonyl stress” in long-term uremic complications.Kidney Int1999; 55: 389–99.
14.
NakayamaM., KawaguchiY., YamadaK., HasegawaT., TakazoeK., KatohN.Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD.Kidney Int1997; 51: 182–6.
15.
LedeboI.On-line hemodiafiltration: Technique and therapy.Adv Ren Repl Ther1999; 6: 195–208.
16.
YuA.W., ManahanF.J., FilkinsJ.P., MohammedM.S., SoundararajanR., McShaneA.P.Peritoneal dialysis using bicarbonate-containing solution sterilized by ultrafiltration.Int J Artif Organs1991; 14: 463–5.
17.
BrunkhorstR., FrommS., WrengerE., BerkeA., PetersenR., RiedeG.Automated peritoneal dialysis with ‘on-line’-prepared bicarbonate-buffered dialysate: Technique and first clinical experiences.Nephrol Dial Transplant1998; 13: 3189–92.
